Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

14.07
Delayed Data
As of 3:59pm ET
 -0.04 / -0.28%
Today’s Change
3.82
Today|||52-Week Range
16.94
+130.66%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close14.11
Today’s open14.10
Day’s range13.41 - 14.29
Volume309,494
Average volume (3 months)2,016,484
Market cap$461.7M
Dividend yield--
Data as of 3:59pm ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)-123.88%
Earnings growth (this year)+21.17%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.91%
P/E ratioNM
Price/Sales7,008.84
Price/Book9.29

Competitors

 Today’s
change
Today’s
% change
AVEOAveo Pharmaceuticals...-0.06-1.46%
SVASinovac Biotech Ltd+0.02+0.29%
CRBPCorbus Pharmaceutica...0.000.00%
DEPODepomed Inc-0.02-0.34%
Data as of 4:00pm ET, 09/21/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$18.5K
Annual profit (last year)-$31.8M
Net profit margin-171,945.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts